Benzoyl Peroxide — Membership Pricing
Benzoyl Peroxide is not confirmed for no-additional-cost pricing. Membership pricing may be available; confirm the price with the dispensing pharmacy.
Benzoyl Peroxide Pricing
| Pricing type | Price |
|---|---|
| TheDrugClub | Membership pricing may be available |
| Typical Retail | $89.99 |
Membership pricing may be available; confirm the price with the dispensing pharmacy.
About Benzoyl Peroxide
Benzoyl Peroxide is a prescription medication. Ask your doctor if Benzoyl Peroxide is right for you.
Other strengths and forms of Benzoyl Peroxide
Conditions Treated with Benzoyl Peroxide
How to Check Benzoyl Peroxide Pricing
- Join TheDrugClub for $19.95/month
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available membership pricing
Benzoyl Peroxide at Participating Pharmacies
- CVS Pharmacy
- Walgreens
- Walmart Pharmacy
- Rite Aid
- Kroger Pharmacy
- Costco Pharmacy
- Albertsons
- Safeway
- Publix Pharmacy
- H-E-B Pharmacy
Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.
Related medications
Other medications associated with the same conditions in this catalog.
Also listed for Acne
Also listed for Acne Vulgaris
Other medications in Dermatology
What Benzoyl Peroxide is approved for (FDA label)
EPSOLAY is indicated for the treatment of inflammatory lesions of rosacea in adults. EPSOLAY is indicated for the treatment of inflammatory lesions of rosacea in adults. ( 1 )
Source: Read the full FDA label on DailyMed. Label effective date: August 11, 2025.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Dosage forms and strengths for Benzoyl Peroxide (FDA label)
Cream, 5%. Each gram of EPSOLAY contains 50 mg of benzoyl peroxide in a white to off-white base. Cream, 5%. ( 3 )
Source: FDA prescribing information (DailyMed). Set ID: 641981e6-460b-44dd-8146-306c47e5367c. SPL document ID: a27367f0-2505-460d-98a1-20fe24f41657. Label effective date: August 11, 2025. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Adverse reactions for Benzoyl Peroxide (FDA label)
Most common adverse reactions (incidence ≥ 1%) are application site reactions: pain, erythema, pruritis and edema. ( 6.1 ) To report SUSPECTED ADVERSE REACTIONS, contact Mayne Pharma at 1-844-825-8500 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. In two randomized, double-blind, vehicle-controlled trials, adult subjects with rosacea applied EPSOLAY (N = 488) or vehicle (N = 234) once daily for 12 weeks.
Source: FDA prescribing information (DailyMed). Set ID: 641981e6-460b-44dd-8146-306c47e5367c. SPL document ID: a27367f0-2505-460d-98a1-20fe24f41657. Label effective date: August 11, 2025. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Contraindications for Benzoyl Peroxide (FDA label)
EPSOLAY is contraindicated in patients with a history of hypersensitivity reactions to benzoyl peroxide or any components of the formulation in EPSOLAY [ see Warnings and Precautions (5.1) ]. A history of a serious hypersensitivity reactions to benzoyl peroxide or any component of the formulation in EPSOLAY. ( 4 )
Source: FDA prescribing information (DailyMed). Set ID: 641981e6-460b-44dd-8146-306c47e5367c. SPL document ID: a27367f0-2505-460d-98a1-20fe24f41657. Label effective date: August 11, 2025. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Warnings and precautions for Benzoyl Peroxide (FDA label)
Hypersensitivity: Severe hypersensitivity reactions, including anaphylaxis and angioedema, have been reported with the use of benzoyl peroxide products. ( 5.1 ) Skin irritation/contact dermatitis: Erythema, scaling, dryness, stinging/burning, irritation and allergic contact dermatitis may occur with use of EPSOLAY and may necessitate discontinuation. ( 5.2 ) Photosensitivity: Avoid or minimize exposure to natural or artificial sunlight and use sun protection measures. ( 5.3 ) 5.1 Hypersensitivity Hypersensitivity reactions, including anaphylaxis, angioedema, and urticaria, have been reported with the use of benzoyl peroxide products. If a serious hypersensitivity reaction occurs, discontinue EPSOLAY immediately and initiate appropriate therapy. 5.2 Skin Irritation/Contact Dermatitis Erythema, scaling, dryness and stinging/burning may be experienced with use of EPSOLAY. Irritation and contact dermatitis may occur. Apply a moisturizer and discontinue EPSOLAY if symptoms do not improve. Avoid application of EPSOLAY to cuts, abrasions, eczematous or sunburned skin. 5.3 Photosensitivity Benzoyl peroxide may increase sensitivity to sunlight.
Source: FDA prescribing information (DailyMed). Set ID: 641981e6-460b-44dd-8146-306c47e5367c. SPL document ID: a27367f0-2505-460d-98a1-20fe24f41657. Label effective date: August 11, 2025. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.